Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Vincerx Pharma, Inc. (VINC) had Stock-Based Compensation of $3.47M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-30.07M |
|
-- |
|
-- |
|
$31.46M |
|
$-31.46M |
|
$1.39M |
|
$-30.07M |
|
$-30.07M |
|
$-30.07M |
|
$-30.07M |
|
$-30.07M |
|
$-30.07M |
|
$-31.46M |
|
$-30.58M |
|
1.90M |
|
1.90M |
|
$-15.85 |
|
$-15.85 |
|
| Balance Sheet Financials | |
$6.41M |
|
-- |
|
$1.59M |
|
$8.01M |
|
$5.28M |
|
-- |
|
-- |
|
$5.28M |
|
$2.72M |
|
$2.72M |
|
$2.72M |
|
2.24M |
|
| Cash Flow Statement Financials | |
$-26.13M |
|
$0.21M |
|
$17.99M |
|
$12.85M |
|
$5.07M |
|
$-7.79M |
|
|
Stock-Based Compensation |
$3.47M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.13M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1104.04% |
|
-1104.04% |
|
-375.69% |
|
-1104.04% |
|
$1.22 |
|
$-13.77 |
|
$-13.77 |
|